As an update to the previous release late last year, Japan’s regulatory body, the Pharmaceutical and Medical Device Agency (PMDA), has released its translated English version of the process for conducting remote compliance inspections for drugs and regenerative medical products last week. The document provides guidance for applicants to prepare for submission, as well as outlines the various steps of the remote inspection process.

Read more here.

More on: